rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Peter Clausen

Cso/COO

Company insider

Files Form 4 as: Cso/COO, Cytomedix Inc Com New.

Every Form 4 they filed

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
5 May 2016
Last trade
29 Jun 2026
Last filed
2 Jul 2026

Companies traded

Where they are an officer
Cytomedix Inc Com NewOfficer · Medical Devices · last 29 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
29 Jun 2026filed 2 Jul 2026Cytomedix Inc Com Newoption or derivative · Medical DevicesSEC FORM 4 Code A—65,000 at $0.00filing
29 Jun 2026filed 2 Jul 2026Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—65,000 at $0.00filing
31 Jul 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code M$74K183,853 at $0.40filing
20 May 2024filed 21 May 2024Nuo TherapeuticsSEC FORM 4 Code A$11K15,000 at $0.75filing
19 Dec 2023filed 20 Dec 2023Nuo TherapeuticsSEC FORM 4 Code A$10K20,000 at $0.50filing
1 Aug 2023filed 3 Aug 2023Nuo TherapeuticsSEC FORM 4 Code A$50K25,000 at $2.00filing
6 Jun 2022filed 15 Jun 2022Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—275,000 at $0.00filing
29 Apr 2022filed 2 May 2022Nuo TherapeuticsSEC FORM 4 Code A$25K25,000 at $1.00filing
4 Mar 2022filed 26 Apr 2022Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—43,328 at $0.00filing
31 Dec 2018filed 3 Jan 2019Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—81,250 at $0.00filing
9 Aug 2018filed 4 Aug 2025Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—183,853 at $0.00filing
9 Aug 2018filed 13 Aug 2018Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—183,853 at $0.00filing
9 Jan 2017filed 11 Jan 2017Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—80,000 at $0.00filing
5 May 2016filed 29 Jul 2016Nuo TherapeuticsSEC FORM 4 Code J—1,201filing
5 May 2016filed 29 Jul 2016Nuo TherapeuticsSEC FORM 4 Code J—3,474filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Scott M. PittmanDirector and 10% owner · Director and 10% owner at Nuo Therapeutics, filing Form 4 there in the last year
David Emerson JordenCEO/CFO · CEO/CFO at Nuo Therapeutics, filing Form 4 there in the last year
C. Eric WinzerDirector · Director at Nuo Therapeutics, filing Form 4 there in the last year
Paul MintzDirector · Director at Nuo Therapeutics, filing Form 4 there in the last year